◆ 会议时间:2022年9月16日至20日
◆ 会议地点:意大利 米兰(Milan, Italy)
◆ 会议简介:
2022年第40届欧洲白内障与屈光外科医师协会(ESCRS)大会/年会将于2022年9月16日至20日在意大利米兰举行。
欧洲白内障与屈光外科医师学会(ESCRS)成立于1991年,其宗旨是促进植入和屈光手术领域的教育和研究,推动和促进眼科学的研究和实践。ESCRS寻求促进和支持人工晶体植入术和屈光手术领域的研究,并传播其有价值的研究结果。ESCRS现在全球130个国家和地区拥有超过7500名成员。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
ESCRS 2022 - 40th Congress of the European Society of Cataract and Refractive Surgeons
DATE: 16 - 20 September, 2022
VENUE: MiCo, Milano Convention Centre, Milan, Italy
摘要征集:
IMPORTANT DATES
- Abstract submission opening: Late January 2022
- Extended abstract submission deadline: 18 March 2022, 23:59 CET
- Notifications to submitters: End May 2022
- Abstracts received after the deadline will not be accepted!
点此提交摘要>>>Submit Abstract>>>
DOWNLOAD THE SUBMISSION GUIDELINES
Dear ESCRS Community
We are pleased to inform you that the 40th Congress of the ESCRS will take place at the MiCo Milano Convention Centre, Milan, Italy from Friday 16 to Tuesday 20 September 2022.
The Congress will be a primarily face-to-face event, supported by a number of virtual elements. ESCRS is proud to have been among the first international healthcare societies to return to “live” meetings in 2021 and is excited to continue in this direction in 2022.
The Congress will take place in conformity with locally applicable sanitary restrictions as of September 2022. We are closely monitoring the situation and will regularly update our community as the situation evolves over the coming months.
ESCRS has taken on board various feedback received following the 2021 ESCRS Congress in Amsterdam to the effect that there is a strong desire to refocus on face-to-face meetings, networking, satellite symposia and exhibition. Nevertheless, the virtual world has become part of our reality. Consequently, sessions will still be streamed via the virtual conferencing platform.
Last but by no means least, I would like to highlight my commitment as ESCRS President to focus on sustainability in all areas of our activities as a society. This includes our Congress and meetings. We are therefore embarking on a holistic sustainability audit and improvement programme and are confident all stakeholders in our Congress will join us in this journey.
We very much look forward to welcoming you to the ESCRS 2022 Congress and hope that your stay in Milan will be informative, educational and enjoyable!
Kind regards
Prof. Oliver Findl
President, ESCRS
注册费:
Registration Fees (Applicable VAT not included)
Face-to-Face: Milan |
(Applicable VAT not included) |
Registration Category |
Early bird until 29 June 2022 |
Late rates from 30 June 2022 |
ESCRS Member |
EURO 500.00 |
EURO 650.00 |
Non Member |
EURO 600.00 |
EURO 750.00 |
Trainee / Resident |
EURO 150.00 |
EURO 200.00 |
Nurse / Technician |
EURO 150.00 |
EURO 200.00 |
Allied Healthcare Professional |
EURO 250.00 |
EURO 350.00 |
Corporate |
EURO 1,100.00 |
EURO 1,500.00 |
Researcher (Employee) from Exhibiting / Sponsoring Companies |
EURO 750.00 |
EURO 750.00 |
Glaucoma Day |
EURO 150.00 |
EURO 150.00 |
Cornea Day |
EURO 150.00 |
EURO 150.00 |
Virtual Attendance |
(Applicable VAT not included) |
Registration Category |
Early bird until 29 June 2022 |
Late rates from 30 June 2022 |
ESCRS Member |
EURO 375.00 |
EURO 490.00 |
Non Member |
EURO 450.00 |
EURO 565.00 |
Trainee / Resident |
EURO 110.00 |
EURO 135.00 |
Nurse / Technician |
EURO 110.00 |
EURO 135.00 |
Allied Healthcare Professional |
EURO 160.00 |
EURO 210.00 |
Corporate |
EURO 550.00 |
EURO 750.00 |
What’s included in the registration fee?
CONGRESS PASS – Milan
- Access to the conference centre for the duration of the Congress
- Access to the Exhibition
- Access to all sessions (some speciality days & Wetlabs subject to additional charge)
- Congress Material
- Access to the virtual platform during the live event and for 3-months post-event
- Access to the ESCRS On Demand for Members only
VIRTUAL PASS – Online
- Access to the virtual platform during the live event and for 3-months post-event
- Access to the ESCRS On Demand for Members only
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|